As Blyumin put it, they were given limited use authorizations to compound these drugs that otherwise they shouldnt be able to, because theyre on patent. Now, those shortages have ended, and compounding pharmacies no longer have a legal basis for producing identical copies of GLP-1s
The LactMed database reports minimal transfer into breast milk, and it has decades of safety data in lactating women
*Correspondence: Jin-Hong Min, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
MOTS-c is a potential exercise mimic
Omega 3 c tc dng chng vim v n hot ng trn con ng sinh ha ging nh NSAID
Endogenous glucagon-like peptide (GLP)-1 as alternative for GLP-1 receptor agonists: Could this work and how